Epinastine: topical ophthalmic second generation antihistamine without significant systemic side effects

Shilpi Pradhan Cornea Fellow and Clinical Instructor, University of Pittsburgh Medical Center, Eye and Ear Institute, 203 Lothrop Street, Pittsburgh, PA 15213, USA

, MD,

Kumar Abhishek Internal Medicine Hospitalist, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA 15212, USA

, MD &

Francis Mah Assistant Professor, Co-Medical Director, University of Pittsburgh Medical Center, Eye and Ear Institute, Ophthalmology, Charles T. Campbell Ophthalmic Microbiology Laboratory, 203 Lothrop Street, Pittsburgh, PA 15213, USA +1 412 647 2214; +1 412 647 5119; [email protected]

, MD

Abstract

Background: Epinastine is a topical ophthalmic antihistamine and a mast cell stabilizer indicated for treatment of symptoms associated with allergic conjunctivitis. Objective: The objective of this review is to provide a comprehensive overview of the pharmacology, clinical efficacy, tolerability and safety of epinastine 0.05% ophthalmic solution. Methods: Medline literature review from 1950 to 2008. Conclusions: Epinastine 0.05% ophthalmic solution was found to be a safe and effective medication for the relief of symptoms of allergic conjunctivitis. Epinastine demonstrates very low CNS and cardiac toxicity.

Keywords::

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Epinastine: topical ophthalmic second generation antihistamine without significant systemic side effects

Information for

Open access

Opportunities

Help and information

Epinastine: topical ophthalmic second generation antihistamine without significant systemic side effects

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature